Case Reports in Hematology / 2013 / Article / Fig 2

Case Report

Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma

Figure 2

Mediastinal tumor refractory to salvage radiotherapy. (a) CT shows relapsed superior mediastinal tumor before radiotherapy. (b) CT reveals progression of the superior mediastinal tumor 2 months after completion of radiotherapy.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.